Skip to main content
. 2018 Apr 18;3(2):e00103-18. doi: 10.1128/mSphere.00103-18

TABLE 2 .

Antibiotic resistance gene carriage in the placebo and erythromycin groups at baseline and at the end of erythromycin treatment (48 weeks)

Resistance gene % gene carriage in indicated group
P value
(Fisher's exact
test, 48 wks)
Placebo
Erythromycin
Baseline 48 wks Baseline 48 wks
erm(A) 2.4 2.4 4.7 4.7 >0.99
erm(B) 53.6 56.1 60.5 69.8 0.26
erm(C) 17.1 12.2 11.6 14.0 >0.99
erm(F) 53.6 48.8 41.9 44.2 0.82
msrA 0.0 2.4 0.0 0.0 0.49
mef 100.0 95.1 100.0 97.7 0.61